Question 1

How many shares of GALT does MARSHALL WACE, LLP own?

Accepted Answer

As of 2026-Q2, MARSHALL WACE, LLP holds 831,010 shares of GALT (GALECTIN THERAPEUTICS INC).

Question 2

What is MARSHALL WACE, LLP's GALT position worth?

Accepted Answer

As of 2026-Q2, MARSHALL WACE, LLP's GALT position is worth $3.9M.

Question 3

Is MARSHALL WACE, LLP buying or selling GALT?

Accepted Answer

In 2026-Q2, MARSHALL WACE, LLP decreased their GALT position (-31.9% change in shares).

Question 4

When did MARSHALL WACE, LLP first buy GALT?

Accepted Answer

Based on available 13F filings, MARSHALL WACE, LLP first reported a position in GALT in 2024-Q3. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	831,010	-31.9%	$3.9M	0.0%	$4.64	0
2026-Q1	Increased	1.2M	+102.6%	$3.4M	0.0%	$2.98	43
2025-Q4	Increased	602,134	+8.6%	$2.5M	0.0%	$4.08	28
2025-Q3	Increased	554,261	+1723.2%	$2.4M	0.0%	$4.22	42
2025-Q2	New	30,400	-	$64,144	0.0%	$2.33	29
2024-Q4	Exited	0	-100.0%	$0	0.0%	$1.10	0
2024-Q3	Increased	52,259	+177.6%	$143,712	0.0%	$2.71	36

GALTShowing 7 of 10 quarters

GALT
Showing 7 of 10 quarters